BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9315092)

  • 1. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T; Kujovich J; Reis M; Newman B; Druker BJ
    Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shb is a ubiquitously expressed Src homology 2 protein.
    Welsh M; Mares J; Karlsson T; Lavergne C; Bréant B; Claesson-Welsh L
    Oncogene; 1994 Jan; 9(1):19-27. PubMed ID: 8302579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSH2: a novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells.
    Oda T; Muramatsu MA; Isogai T; Masuho Y; Asano S; Yamashita T
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1078-86. PubMed ID: 11700021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    Oncogene; 1997 Feb; 14(5):507-13. PubMed ID: 9053848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein.
    Liu J; Wu Y; Arlinghaus RB
    Cancer Res; 1996 Nov; 56(22):5120-4. PubMed ID: 8912843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
    Juang JL; Hoffmann FM
    Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn.
    Ishino M; Ohba T; Sasaki H; Sasaki T
    Oncogene; 1995 Dec; 11(11):2331-8. PubMed ID: 8570184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
    Yu HH; Zisch AH; Dodelet VC; Pasquale EB
    Oncogene; 2001 Jul; 20(30):3995-4006. PubMed ID: 11494128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation of murine Crkl.
    de Jong R; Haataja L; Voncken JW; Heisterkamp N; Groffen J
    Oncogene; 1995 Oct; 11(8):1469-74. PubMed ID: 7478571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354.
    Hawk N; Sun T; Xie S; Wang Y; Wu Y; Liu J; Arlinghaus RB
    Cancer Res; 2002 Jan; 62(2):386-90. PubMed ID: 11809685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcr phosphorylated on tyrosine 177 binds Grb2.
    Ma G; Lu D; Wu Y; Liu J; Arlinghaus RB
    Oncogene; 1997 May; 14(19):2367-72. PubMed ID: 9178913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the c-Abl and Bcr-Abl tyrosine kinases.
    Hantschel O; Superti-Furga G
    Nat Rev Mol Cell Biol; 2004 Jan; 5(1):33-44. PubMed ID: 14708008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequence analysis of human abl and bcr-abl cDNAs.
    Fainstein E; Einat M; Gokkel E; Marcelle C; Croce CM; Gale RP; Canaani E
    Oncogene; 1989 Dec; 4(12):1477-81. PubMed ID: 2687768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
    Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
    Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation-dependent yeast two-hybrid system for the identification of the SH2 domain-binding proteins.
    Park D; Yun Y
    Mol Cells; 2001 Oct; 12(2):244-9. PubMed ID: 11710529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of murine STAP-1, the stem-cell-specific adaptor protein containing PH and SH2 domains.
    Masuhara M; Nagao K; Nishikawa M; Sasaki M; Yoshimura A; Osawa M
    Biochem Biophys Res Commun; 2000 Feb; 268(3):697-703. PubMed ID: 10679268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.